Ruthie Amir

Ruthie Amir

Chief Tech/Sci/R&D Officer at SOFWAVE MEDICAL LTD.

58 year
Health Technology
Finance
Consumer Services

Profile

Dr. Ruthie Amir joined Alon Medtech Ventures as the chief medical officer in 2018.
Prior to joining Alon Medtech Dr. Amir served as the director of clinical research and the head of the regulatory department of Syneron Candela from 2008 to 2017.
Dr. Ruthie Amir graduated from Ben Gurion University Medical School in 1989.
From 1996-2000, she completed her post-doctoral fellowship in the Department of Human Genetic, at Baylor College of Medicine, Houston, USA where she worked on the genetic basis of Rett Syndrome.
Between 2000-2003 she completed a post-doctoral fellowship in the Department of Cell Biology, Faculty of Medicine, Technion.

Ruthie Amir active positions

CompaniesPositionStart
SOFWAVE MEDICAL LTD. Chief Tech/Sci/R&D Officer 2018-09-30
EPITOMEE MEDICAL LTD Corporate Officer/Principal 2018-04-30
Corporate Officer/Principal 2017-08-31
All active positions of Ruthie Amir

Former positions of Ruthie Amir

CompaniesPositionEnd
SYNERON MEDICAL LTD. Chief Tech/Sci/R&D Officer 2016-12-31
See the detail of Ruthie Amir's experience

Training of Ruthie Amir

Medical School For International Health Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ruthie Amir's experience

Connections

53

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
EPITOMEE MEDICAL LTD

Health Technology

SOFWAVE MEDICAL LTD.

Health Technology

Private companies2

Health Technology

Finance

See company connections